Hospital Universitario Marqués de Valdecilla -ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2023

  1. High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome

    Journal of Autoimmunity

  2. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 61

2022

  1. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review

    Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

  3. Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice

    Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558

2020

  1. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts

    Rheumatology International

2015

  1. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the spanish rheumatology society lupus registry (RELESSER) with emphasis on complete versus incomplete lupus differences

    Medicine (United States), Vol. 94, Núm. 1, pp. e267

2014

  1. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

  2. Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

    Joint Bone Spine, Vol. 81, Núm. 2, pp. 164-168

  3. Cardiovascular risk assessment in rheumatoid arthritis: Impact of the EULAR recommendations on a national calibrated score risk index

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 237-242

  4. Évaluation du risque cardiovasculaire selon l'indice SCORE national calibré chez les patients atteints de rhumatisme psoriasique sans maladie cardiovasculaire clinique évidente ni de facteurs de risque classiques d'athérosclérose

    Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 2, pp. 154-158

2013

  1. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

  2. Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease

    Human Immunology, Vol. 74, Núm. 2, pp. 230-233

2012

  1. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: The LESIMAB study

    Lupus, Vol. 21, Núm. 10, pp. 1063-1076

  2. NPSR1 gene is associated with reduced risk of rheumatoid arthritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1166-1170

2011

  1. Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region

    Journal of Rheumatology, Vol. 38, Núm. 11, pp. 2290-2296

  2. No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data

    Human Immunology, Vol. 72, Núm. 9, pp. 779-782

  3. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples

    Arthritis and Rheumatism, Vol. 63, Núm. 2, pp. 365-372